Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EPS Bio TechnologyROCO:4183 -3.52%70 Days Payable is 69.10 as of Jun. 2026, which is 2% below its 10-year median of 70.43. GuruFocus rates ROCO:4183 with a GF Score™ of 70/100 and a GF Value™ of NT$18.34 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 793 Medical Devices & Instruments companies, EPS Bio Technology ranks better than 58.76% on this metric.
The historical rank and industry rank for EPS Bio Technology's Days Payable or its related term are showing as below:
ROCO:4183'
s Days Payable Range Over the Past 10 Years
Min: 63.42 Med: 70.43 Max: 85
Current: 85
During the past 13 years, EPS Bio Technology's highest Days Payable was 85.00. The lowest was 63.42. And the median was 70.43.
ROCO:4183's Days Payable is ranked better than 58.76% of 793
companies
in the Medical Devices & Instruments industry
Industry Median: 68.47
vs ROCO:4183: 85.00
EPS Bio Technology's Days Payable
declined
from Jun. 2025 (90.55) to Jun. 2026 (69.10).
It may suggest that EPS Bio Technologyaccelerated paying its suppliers.
The historical data trend for EPS Bio Technology's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4183 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, EPS Bio Technology's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EPS Bio Technology Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, EPS Bio Technology's Days Payable distribution charts can be found below:
* The bar in red indicates where EPS Bio Technology's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
EPS Bio Technology's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EPS Bio Technology (ROCO:4183) has a Days Payable of 69.10 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on EPS Bio Technology and its competitors. This is near median its historical median of 70.43. Over the past decade, EPS Bio Technology's Days Payable has ranged from 63.42 to 85.00. According to the industry distribution chart, EPS Bio Technology ranks #327 out of 793 companies in the Medical Devices & Instruments industry, placing it in the top 41.2%.
Is EPS Bio Technology's Days Payable too high?
EPS Bio Technology's current Days Payable of 69.10 is near median its 10-year median of 70.43. Over the past 10 years, this metric has ranged from a low of 63.42 to a high of 85.00. The Medical Devices & Instruments industry median Days Payable is 68.47. EPS Bio Technology's value of 69.10 is 0.9% above this industry median. Based on the distribution chart, EPS Bio Technology ranks #327 out of 793 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, EPS Bio Technology has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EPS Bio Technology's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, EPS Bio Technology ranks #327 out of 793 companies for Days Payable. This puts EPS Bio Technology in the upper half of its industry. The industry median Days Payable is 68.47. EPS Bio Technology's value of 69.10 is 0.9% above this benchmark. Historically, EPS Bio Technology's own Days Payable has ranged from 63.42 to 85.00 over the past decade. While the company's 10-year median is 70.43 vs. the industry median of 68.47, EPS Bio Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.47, based on 793 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EPS Bio Technology's current Days Payable of 69.10 is 0.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on EPS Bio Technology and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EPS Bio Technology's current Days Payable is 69.10, which is near median its own 10-year median of 70.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EPS Bio Technology stock overvalued right now?
Based on GuruFocus' analysis, EPS Bio Technology (ROCO:4183) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$18.34, compared to a current price of NT$13.70 — trading 25.3% below its estimated fair value. The current Days Payable is 69.10, which is near median its 10-year median of 70.43 and 0.9% above the Medical Devices & Instruments industry median of 68.47. EPS Bio Technology's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For EPS Bio Technology (ROCO:4183), the current Days Payable is 69.10 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EPS Bio Technology (ROCO:4183) Overvalued in 2026?
Based on GuruFocus' analysis, EPS Bio Technology stock appears to be undervalued.
The current stock price of NT$13.70 is trading 25.3% below its estimated GF Value™ of NT$18.34.
GuruFocus considers EPS Bio Technology to be Modestly Undervalued.
Key valuation signals for ROCO:4183:
Days Payable: 69.10 (near median its 10-year median of 70.43)
GF Value™: NT$18.34 vs. price of NT$13.70 (25.3% below fair value)
Industry Position: 0.9% above the Medical Devices & Instruments median (#327 of 793)
No single metric tells the full story. See the ROCO:4183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EPS Bio Technology Corp operates in medical equipment manufacturing, international trade, intellectual property, and research, design, development, manufacture and sale of blood glucose measuring system and cirrhosis testing system. Its products include Test sheet and Glucose machine. Geographically it operates in Germany, Iran, Kingdom of Saudi Arabia, Switzerland, Las Vegas, and Others with majority of the revenue deriving from Germany.
70GF Score
Get the complete analysis for ROCO:4183
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4183 has been successfully added to your 
